HTFL — Heartflow, Inc. Common Stock stock price, charts and financials

QT66Heartflow, Inc. Common Stock

Heartflow, Inc. Common Stock (NASDAQ: HTFL) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
50.75
+1.18+2.38%
OverviewShort InterestFilings
HTFLQT66Heartflow, Inc. Common Stock·NASDAQ
50.75+2.38%
News
Up 2.4% — 12,278 Shares in Heartflow, Inc. $HTFL Bought by Amundi (defenseworld.net).
Medium confidence
TA
Loading chart...
Signal & projected range
Insider open-market saleHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
DOCS-1.73%$26.11WAY-3.21%$25.66HNGE+0.19%$94.90PRVA-1.19%$19.85HQY+0.67%$95.14BTSG+0.32%$56.78OMCL-1.20%$32.23TEM-3.14%$77.84
Snapshot
Index-P/E-EPS (ttm)-1.42Insider Own30.53%Shs Outstand86.24MPerf Week1.74%
Market Cap4.38BForward P/E-EPS next Y-0.26Insider Trans-9.33%Shs Float66.29MPerf Month11.46%
Enterprise Value4.37BPEG4.94EPS next Q-0.10Inst Own-Short Float9.15%Perf Quarter50.86%
Income-118.17MP/S20.64EPS this Y70.78%Inst Trans-Short Ratio3.37Perf Half Y96.02%
Sales212.07MP/B15.68EPS next Y38.10%ROA-34.36%Short Interest6.07MPerf YTD74.10%
Book/sh-P/C-EPS next 5Y-ROE-42.25%52W High52.22 -2.82%Perf Year59.79%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-23.67%52W Low20.13 152.11%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y-Gross Margin80.08%Volatility4.47% 4.99%Perf 5Y-
Dividend TTM-EV/Sales20.60EPS Y/Y TTM7.19%Oper. Margin-34.31%ATR (14)2.49Perf 10Y-
Dividend Ex-Date-Quick Ratio5.08Sales Y/Y TTM68.25%Profit Margin-55.82%RSI (14)67.52Recom2.17
Dividend Gr. 3/5Y-Current Ratio5.08EPS Q/Q-16.67%SMA203.53%Beta1.61Target Price44.57
Payout0.00%Debt/Eq0.10Sales Q/Q48.84%SMA5036.03%Rel Volume3.30Prev Close49.57
Employees843LT Debt/Eq0.05EarningsNov 11SMA20064.98%Avg Volume2.00MPrice50.75
IPO DateAug 07, 2025Option/ShortYes / YesEPS/Sales Surpr.47.64% 13.15%Net Debt/EBITDA0.07Volume6,605,123Change2.38%
Analyst Ratings
DateActionAnalystRatingTarget
Sep-09-26InitiatedUBSNeutral$55
Aug-14-26ReiteratedStifel Nicolaus$40 → $45
Aug-14-26ReiteratedRobert W. Baird$34 → $45
Aug-14-26ReiteratedCanaccord GenuityBuy$37 → $45
Aug-14-26ReiteratedMorgan StanleyEqual Weight$35 → $40
Aug-14-26ReiteratedPiper SandlerOverweight$38 → $45
Jul-31-26InitiatedBairdOutperform$34
Jul-15-26ReiteratedStifel Nicolaus$35 → $40
May-15-26ReiteratedCanaccord GenuityBuy$35 → $37
May-15-26ReiteratedWells FargoOverweight$38 → $37
Latest News· Times ET
Sep-17-26
Sep-17-2611:15PM
12,278 Shares in Heartflow, Inc. $HTFL Bought by Amundidefenseworld.net
Sep-16-26
Sep-16-2612:10AM
John C.M. Farquhar Sells 35,010 Shares of Heartflow (NASDAQ:HTFL) Stockdefenseworld.net
Sep-15-26
Sep-15-2611:36AM
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week Highfool.com
Sep-11-26
Sep-11-2603:10PM
HeartFlow, Inc. (HTFL) Presents at Wells Fargo 21st Annual Healthcare Conference - SlideshowSeekingAlpha
Sep-10-26
Sep-10-2611:45PM
Heartflow (NASDAQ:HTFL) versus American Well (NYSE:AMWL) Financial Analysisdefenseworld.net
Sep-05-26
Sep-05-2609:51PM
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week Highfool.com
Sep-04-26
Sep-04-2607:10AM
Baron SMID Cap ETF Q2 2026 Portfolio ActivitySeekingAlpha
Sep-01-26
Sep-01-2601:18AM
Bank of New York Mellon Corp Makes New $19.10 Million Investment in Heartflow, Inc. $HTFLdefenseworld.net
Aug-29-26
Aug-29-2612:00AM
BlackRock Inc. Makes New $152.50 Million Investment in Heartflow, Inc. $HTFLdefenseworld.net
Aug-27-26
Aug-27-2610:48PM
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Halfglobenewswire.com
12:01PM
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conferenceglobenewswire.com
Aug-20-26
Aug-20-2607:40AM
HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?fool.com
Aug-16-26
Aug-16-2608:31AM
Heartflow (HTFL) Rockets 46%: What Analysts Say and Where Hedge Funds StandYahoo
05:32AM
HeartFlow: An Impressive MedTech Growth Playseekingalpha.com
Aug-14-26
Aug-14-2603:24PM
Why Heartflow Stock Soared Todayfool.com
Company

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue212176126—
Cost of Goods Sold Incl. D&A424131—
Gross Profit16913594—
Selling, General and Administrative Excl. Other159134112—
Research and Development846544—
Other Operating Expense
000—
Operating Income-73-64-61—
Interest Expense31523—
Unusual Expense
————
Non-Operating Income (Expense)-42-38-12—
Net Income Before Taxes-119-117-96—
Income Taxes
000—
Consolidated Net Income-118-117-96—
Net Income From Continuing Operations-118-117-96—
Net Income-118-117-96—
EPS (Recurring)-1.42-1.37-1.53—
EPS (Basic, Before Extraordinaries)-1.42-1.37-1.53—
EPS (Diluted)-1.42-1.37-1.53—
EBITDA-108-93-65—
Other After Tax Adjustments
————
Stock Option Compensation Expense
————
Price To Earnings Ratio
————
Price To Sales Ratio20.5914.08——
Gross Margin79.7276.7074.60—
Operating Margin-34.43-36.36-48.41—
Net Margin-55.66-66.48-76.19—
Shares Outstanding868563—
Market Capitalization4,3652,478——
Operating Lease Expense
————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$55.29$45.45$35.62$25.79$15.95● Close Price0.00M15.27M30.55M45.82M61.09MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Verghese VikramChief Financial OfficerSep 18 '26Sale50.7516,766850,926155,183Sep 18
Verghese VikramChief Financial OfficerSep 17 '26Sale50.117,579379,816171,949Sep 18
Verghese VikramChief Financial OfficerSep 15 '26Sale50.0166833,408179,528Sep 15
Verghese VikramChief Financial OfficerSep 14 '26Sale50.244,593230,744180,196Sep 15
Verghese VikramChief Financial OfficerSep 11 '26Sale50.0629,7141,487,459184,789Sep 15
Farquhar John C.M.Chief Executive OfficerSep 11 '26Sale50.003,890194,500321,914Sep 14
Farquhar John C.M.Chief Executive OfficerSep 10 '26Sale46.4235,0101,625,105325,804Sep 14
Verghese VikramChief Financial OfficerSep 08 '26Sale50.036,640332,212214,503Sep 10
Verghese VikramChief Financial OfficerSep 03 '26Sale49.6927,5401,368,471221,143Sep 04
Verghese VikramChief Financial OfficerSep 02 '26Sale50.605,876297,326248,683Sep 04
Farquhar John C.M.Chief Executive OfficerAug 21 '26Sale50.0027,2301,361,500360,814Aug 25
Farquhar John C.M.Chief Executive OfficerAug 18 '26Sale45.0032,6761,470,420388,044Aug 20
Rogers CampbellChief Medical OfficerAug 17 '26Option Exercise19.009,219175,16195,678Aug 19
Rogers CampbellChief Medical OfficerAug 17 '26Sale41.239,219380,09986,459Aug 19
Farquhar John C.M.Chief Executive OfficerAug 14 '26Sale39.0615,560607,774420,720Aug 18
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.